(University of Zurich) An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail. It uses 35 biomarkers to identify the different cell types in breast tumors and its surrounding area compared to the current standard of testing single markers. This increases the precision of tumor analysis and classification – and improves personalized diagnostics for breast cancer patients.

Original source: https://www.eurekalert.org/pub_releases/2020-01/uoz-rbc011720.php